Boehringer Ingelheim is a global organisation and one of the world's 20 leading pharmaceutical companies. Their head quarters are in Germany and they have over 37,000 employees, with 143 affiliated companies around the world.

Boehringer Ingelheim is a group of companies committed to the research through to the production and marketing of pharmaceuticals. They deal with prescription medicines, consumer healthcare, animal health, fine chemicals and biopharmaceuticals. Human pharmaceuticals contribute to over 90% of the group's net sales.

Research and development is carried out in major therapeutic areas -  respiratory, virology, oncology, metabolic diseases, cardiovascular diseases, CNS diseases and Immunology and Inflammation. Research is carried out in Germany, the USA, Canada, Austria, Italy and Japan.

Boehringer Ingelheim's vision is "Value through Innovation" and their approach to employees is "Value through People". Employees are therefore well-rewarded for their efforts with pay, benefits, development and a positive working environment encapsulating a work-life balance and teamwork.

Products

Traditionally Boehringer Ingelheim has focused on Cardiovascular disease, diseases of the CNS and Respiratory disease. They now have new indication areas including Arthritis, Urological disorders and HIV/AIDS.

Some examples of their products include:

Cardiovascular Actilyse, Metalyse

 Aggrenox, Asasantin, Retard

CNS Sifrol, Mirapex

Respiratory - Spiriva, Atrovent, Combivent, Berodual, Duovent

Arthritis - Mobic, Mobec, Mobicox, Movalis, Movatec

Urology - Flomax, Alna, Josir, Pradif, Secotex, Urolosin, Mapelor

HIV/AIDS - Viramune

www.boehringer-ingelheim.com

• Return to list